Geron Corporation reports 2005 second quarter financial results and events and Stephen G. Sudovar elected to Aastrom Biosciences' Board of Directors.

0 Comments | M2 Presswire, August, 2005

M2 PRESSWIRE-8 August 2005-US Financial Network: Geron Corporation reports 2005 second quarter financial results and events and Stephen G. Sudovar elected to Aastrom Biosciences' Board of Directors(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:08082005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU.

Geron Corporation (Nasdaq: GERN) recently reported financial results for the three and six months ended June 30, 2005. For the second quarter of 2005, the company reported a net loss of $3.1 million or $(0.06) per share compared to $8.9 million or $(0.20) per share in the second quarter of 2004. Net loss for the first six months of 2005 was $12.8 million or $(0.23) per share compared to $60.6 million or $(1.41) per share...